N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice.
Ontology highlight
ABSTRACT: Immune responses to factor VIII remain the greatest complication in the treatment of severe hemophilia A. Recent epidemiological evidence has highlighted that recombinant factor VIII produced in baby hamster kidney cells is more immunogenic than factor VIII produced in Chinese hamster ovary cells. Glycosylation differences have been hypothesized to influence the immunogenicity of these synthetic concentrates. In two hemophilia A mouse models, baby hamster kidney cell-derived factor VIII elicited a stronger immune response compared to Chinese hamster ovary cell-derived factor VIII. Furthermore, factor VIII produced in baby hamster kidney cells exhibited accelerated clearance from circulation independent of von Willebrand factor. Lectin and mass spectrometry analysis of total N-linked glycan
SUBMITTER: Lai JD
PROVIDER: S-EPMC6278987 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA